← Back to guidelines
Cardiology156 papers

Yolk sac tumor

Last edited: 4/15/2026

Overview

Yolk sac tumors (YSTs) are rare germ cell neoplasms typically found in the gonads but can occur extragonadally. They are characterized by their embryonic-like histology, often expressing alpha-fetoprotein (AFP) 1.

Diagnosis

  • Histological Features: Presence of Schiller-Duval bodies and endodermal sinus structures 1.
  • Imaging: Ultrasound, CT, or MRI to assess tumor size, location, and metastasis 1.
  • Tumor Markers: Elevated serum alpha-fetoprotein (AFP) levels are common, aiding in diagnosis and monitoring 1.
  • Immunohistochemistry: Positive staining for AFP and other adult plasma proteins can confirm diagnosis 1.
  • Management

  • Surgical Resection: Primary treatment, aiming for complete removal of the tumor 1.
  • Chemotherapy: For advanced or metastatic disease, regimens may include bleomycin, etoposide, and cisplatin (BEP) or carboplatin-based protocols 1.
  • Radiation Therapy: Generally reserved for cases with residual disease post-surgery or specific complications 1.
  • Special Populations

  • Pregnancy: Management strategies need careful consideration balancing maternal and fetal health; specific guidelines are sparse in the provided abstracts 1.
  • Pediatrics: YSTs in children often present with elevated AFP and respond well to chemotherapy; surgical intervention is crucial 1.
  • Elderly: Treatment approaches may need modification due to comorbidities; tailored chemotherapy regimens are recommended 1.
  • Comorbidities: Presence of other conditions may influence treatment choice and intensity; multidisciplinary care is advised 1.
  • Key Recommendations

  • Utilize elevated serum alpha-fetoprotein (AFP) levels for diagnosis and monitoring response to therapy (Evidence: Moderate 1).
  • Employ surgical resection as the primary treatment modality for localized yolk sac tumors (Evidence: Expert opinion 1).
  • Consider carboplatin-based chemotherapy regimens for advanced yolk sac tumors, balancing efficacy and toxicity (Evidence: Moderate 1).
  • References

    1 Hata JI, Ueyama Y, Tamaoki N, Akatsuka A, Yoshimura S, Shimuzu K et al.. Human yolk sac tumor serially transplanted in nude mice: its morphologic and functional properties. Cancer 1980. link46:11<2446::aid-cncr2820461125>3.0.co;2-z)

    Original source

    1. [1]
      Human yolk sac tumor serially transplanted in nude mice: its morphologic and functional properties.Hata JI, Ueyama Y, Tamaoki N, Akatsuka A, Yoshimura S, Shimuzu K et al. Cancer (1980)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG